NuBloom review

What it is

NuBloom is a telehealth practice for women, co-founded by Dr. Marianne Pinkston Mueller, a family and integrative-medicine physician with more than 25 years in practice, who lists a Texas medical license, and by chief executive Jennifer Seroogy. The team includes a fitness director who designs its strength program and a licensed marriage and family therapist who trains its coaches. Its focus is women 40 and older, with care across five areas: weight and metabolism, hormones and menopause, skin and hair, energy and longevity, and gut health. Appointments and prescribers come through its integration with Telegra, a telehealth network certified by LegitScript, and NuBloom displays its own LegitScript seal. It lists 49 served states, every state except Mississippi. It also sells its own line of supplements, which are separate from the prescription plans. NuBloom's terms describe it simply as owned and operated by NuBloom, without a corporate suffix or street address.

How it works

There are two ways in. If you know what you want, you choose a medication, complete a secure medical intake, and a licensed provider reviews whether it's appropriate; if it is, the prescription goes to a U.S. pharmacy and ships to your door. If you want guidance first, NuBloom's lab-based path starts with a wellness intake and a personalized lab panel covering hormones, thyroid, metabolism and inflammation, followed by a virtual visit where a provider reviews your results and recommends treatment. Semaglutide plans require a BMI of 27 or higher. GLP-1s are offered as weekly injections only; NuBloom explains that it doesn't prescribe GLP-1 pills because so little of an oral peptide is absorbed. Members get dosing and injection guides, side-effect tips, a self-paced strength program and an online community, and follow-up visits are available to adjust the plan. The coaching program adds 12 weekly one-on-one sessions on eating patterns, protein, habits and emotional eating.

Pricing transparency

Compounded semaglutide is $149 a month and compounded tirzepatide is $279 a month, each sold as a month-to-month subscription; a microdose tirzepatide plan is $249 a month. The same price is listed for every dose shown, from 0.25 mg to 2.4 mg for semaglutide and 2.5 mg to 15 mg for tirzepatide. NuBloom's terms say the amounts it collects include the medical providers' fees. The 90-day guided program, which pairs medication with weekly coaching, is listed at $499 a month for three months with semaglutide and $599 with tirzepatide, though the semaglutide product page shows $599, so confirm the price at checkout. A non-GLP-1 option, bupropion with naltrexone, is $139 a month. Prescriptions and compounded products are final sale and can't be returned once dispensed, subscription charges aren't refunded once an order ships, and prescription orders can't be canceled once processing starts. Damaged or incorrect orders must be reported within seven days. FSA and HSA cards can be used. Insurance isn't mentioned.

Branded vs compounded

Compounded semaglutide and compounded tirzepatide as weekly injections, a lower-dose tirzepatide plan, and the oral combination of bupropion and naltrexone for people who aren't GLP-1 candidates. Compounded drugs are prepared by a pharmacy for an individual prescription and are not FDA-approved; NuBloom's product pages say they're compounded but don't name the pharmacy that fills them, so ask if that matters to you. Brand-name Wegovy and Zepbound are not offered. Beyond weight loss, the practice treats menopause and perimenopause symptoms, offers gut and inflammation care, and sells peptides and supplements matched to lab results. A search of the FDA warning-letter database for NuBloom returned no letters.

Pros and watch-outs

The evidence behind what NuBloom prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• “Microdosing” GLP-1 drugs: a trend, not a protocol — what the evidence says

  Sub-therapeutic semaglutide and tirzepatide is spreading fast. The pharmacology is clear, the honest part is clearer: efficacy is dose-related, and no trial has tested intentional microdosing.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How NuBloom compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Willow

  Buyers who want every dose priced and the pharmacies named, and will pay more for it

  See Willow →
• Gala Health

  A guided, program-style GLP-1 weight-care experience

  See Gala Health →
• Midi Health

  Women in perimenopause or menopause who want weight care, and possibly hormone therapy, from one clinician, with insurance paying for the visits

  See Midi Health →

More GLP-1 telehealth reviews: 1st Optimal · ZipHealth · Shapely · Steady State Health · SurpassMD · TeleSlim Clinic